OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the ...

U.S. physicians are graduating unprepared to address the leading causes of death in their patients. Cardiometabolic diseases ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Advances in artificial intelligence promise to help chemical engineers discover complex new materials. These materials could ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

In science, ethical guidelines ensure that research takes place in a way that respects public trust and is conducted ...

Abstract: This paper presents a structured literature review that explores the relationship between artificial intelligence and business process modeling. The study focuses on how artificial ...

The Met Office has celebrated one year of “supercomputing as a service” from Microsoft. The occasion presented an opportunity for the weather forecasting and climate prediction organisation to offer ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

After having navigated the challenges as a smaller, emerging competitor to break into therapeutic markets that are dominated by larger competitors, Penumbra is now poised to be acquired by Boston ...

The study presents a multimodal inquiry-based instructional model designed to promote scientific literacy in culturally and linguistically diverse classrooms. The approach integrates historical ...